We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
-12.61%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$2.88B
AUM Growth
-$318M
(-10%)
Cap. Flow
+$207M
Cap. Flow
% of AUM
7.2%
Top 10 Holdings %
Top 10 Hldgs %
61.04%
Holding
99
New
12
Increased
15
Reduced
4
Closed
20
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$145M |
| 2 |
Arvinas
ARVN
|
+$81.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$58.7M |
| 4 |
Revolution Medicines
RVMD
|
+$58.5M |
| 5 |
Allogene Therapeutics
ALLO
|
+$39.8M |
Top Sells
| 1 |
Arcus Biosciences
RCUS
|
+$103M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$41.2M |
| 3 |
Vaxcyte
PCVX
|
+$31.5M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
+$24M |
| 5 |
Exelixis
EXEL
|
+$19.6M |
Sector Composition
| 1 | Healthcare | 99.13% |
| 2 | Financials | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$447M
| $315M | 10.93% |
11,584,280
| – | – |
|
|
APLS
2
DELISTED
Apellis Pharmaceuticals
APLS
| $234M | 8.14% |
5,183,431
| – | – |
|
|
3
Sarepta Therapeutics
SRPT
$1.82B
| $215M | 7.47% |
2,868,145
+798,511
| +39% | +$58.7M |
|
|
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
| $178M | 6.2% |
+1,008,628
| New | +$145M |
|
|
LKFT
5
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $178M | 6.2% |
3,197,500
+1,876
| +0.1% | +$111K |
|
6
AnaptysBio
ANAB
$1.65B
| $153M | 5.3% |
7,521,024
| – | – |
|
7
Xencor
XNCR
$1.1B
| $145M | 5.02% |
5,282,416
+313,660
| +6% | +$7.74M |
|
|
8
Arvinas
ARVN
$526M
| $131M | 4.57% |
3,123,300
+1,619,371
| +108% | +$81.3M |
|
9
Kura Oncology
KURA
$999M
| $122M | 4.23% |
6,638,371
| – | – |
|
|
MORF
10
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $85.7M | 2.98% |
3,951,566
| – | – |
|
11
Acadia Pharmaceuticals
ACAD
$4.43B
| $84.4M | 2.93% |
5,991,479
| – | – |
|
12
Zai Lab
ZLAB
$2.3B
| $84.3M | 2.93% |
2,431,885
+208,673
| +9% | +$7.36M |
|
|
13
Revolution Medicines
RVMD
$39.3B
| $83.4M | 2.9% |
4,278,069
+3,003,972
| +236% | +$58.5M |
|
14
Relay Therapeutics
RLAY
$4.19B
| $62.4M | 2.17% |
3,723,541
+1,432,100
| +62% | +$30.7M |
|
|
RETA
15
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $60M | 2.09% |
1,975,611
| – | – |
|
|
16
Allogene Therapeutics
ALLO
$632M
| $51.2M | 1.78% |
+4,488,200
| New | +$39.8M |
|
17
argenx
ARGX
$54B
| $47.4M | 1.65% |
125,000
| – | – |
|
|
TSVT
18
DELISTED
2seventy bio
TSVT
| $46.1M | 1.6% |
3,495,943
| – | – |
|
19
Nuvation Bio
NUVB
$2.02B
| $45M | 1.56% |
13,896,543
| – | – |
|
20
Atea Pharmaceuticals
AVIR
$383M
| $45M | 1.56% |
6,340,639
| – | – |
|
|
CERE
21
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $43.5M | 1.51% |
1,646,260
| – | – |
|
22
Alector
ALEC
$164M
| $41.2M | 1.43% |
4,056,548
-1,681,900
| -29% | -$16.8M |
|
|
RNAM
23
DELISTED
Avidity Biosciences
RNAM
| $40.1M | 1.39% |
2,759,505
| – | – |
|
24
Design Therapeutics
DSGN
$834M
| $36.9M | 1.28% |
2,634,178
+262,733
| +11% | +$3.55M |
|
25
Voyager Therapeutics
VYGR
$190M
| $28.1M | 0.98% |
4,753,907
+1,196,400
| +34% | +$8.08M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM